📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 5 points (worsening)
💹 Market Data
Market Cap$2.76B
Shares Outstanding233.46M
FloatN/A
Cash$6.71M
Debt$2.03B
Short InterestN/A
🏛 Institutional Holdings
19.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest210.2K
Days to Cover1.0
% of FloatN/A
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for NAD
📊 NAD FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NAD Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.